CDC advisory panel recommends Johnson & Johnson shot as third vaccine readies to hit market
Panel’s recommendation is one of the final steps before the shot hits the American marketplace.
A Centers for Disease Control and Prevention advisory committee voted Sunday to recommend Johnson & Johnson's coronavirus vaccine, one of the final steps before the shot hits the American marketplace.
The panel endorsed the emergency use of the vaccine for people ages 18 and older, one day after the Food and Drug Administration did the same.
CDC Director Rochelle Walensky is expected to accept the committee’s recommendation late Sunday or Monday, allowing vaccinations to begin.
News, Not Noise
- President Biden calls for all employers to give workers paid leave if they need it to get vaccinated
- Census data show long rise in single-parent homes; experts link to wide array of social ills
- Hunter Biden business ambitions in China included building SeaWorld parks, memos show
- Columnist, pundit Juan Williams says TV show host rejected him for not being 'black enough'
- GOP Congresswoman on ending MLB antitrust exemption: 'Make them compete'